Search results
The KDIGO 2024 CKD Guideline provides evidence-based recommendations for healthcare professionals, people with CKD and their caregivers, and policymakers. It covers topics such as CKD evaluation, risk assessment, complications, medication management, and patient-centered care.
- KDIGO Announces Publication of 2024 CKD Guideline
Key highlights of the KDIGO CKD Guideline include guidance...
- Guidelines – KDIGO
KDIGO guidelines are created, reviewed, published and...
- KDIGO Announces Publication of 2024 CKD Guideline
KDIGO guidelines cover various aspects of prevention and management of kidney diseases, such as CKD, AKI, and transplantation. Find evidence-based recommendations, compare with other guideline groups, and access KDIGO apps and newsletter.
13 mar 2024 · Key highlights of the KDIGO CKD Guideline include guidance updates on the measurements of estimated glomerular filtration rate and albuminuria, utilization of CKD risk prediction equations, and personalized treatment recommendations for kidney and cardiovascular risk reductions tailored to individual patient needs and preferences.
31 paź 2023 · This article is published as part of a supplement sponsored by Kidney Disease: Improving Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of the authors and do not necessarily reflect the opinions or recommendations of the International Society of Nephrology or Elsevier.
11 paź 2023 · The Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD) updates the KDIGO 2012 guideline and has been developed with patient partners, clinicians, and researchers around the world, using robust methodology.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024 Apr;105 (4S):S117-S314. doi: 10.1016/j.kint.2023.10.018. Author. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. Collaborators. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group:
The commentary underscores the continued relevance of KDIGO’s recommendations on managing CKD, including the importance of the detection of albuminuria and the incorporation of cystatin C in the measurement of kidney function. It also acknowledges the strong evidence supporting the use of novel agents such as SGLT2 inhibitors, GLP-1 receptor ...
